![Heikki Matti Kalervo Hautsalo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Heikki Matti Kalervo Hautsalo
Chairman at Valo Therapeutics Oy
Network origin in Heikki Matti Kalervo Hautsalo first degree
Entity | Entity type | Industry | |
---|---|---|---|
Valo Therapeutics Oy
![]() Valo Therapeutics Oy Pharmaceuticals: MajorHealth Technology Valo Therapeutics Oy is an immunotherapy company based in Helsinki, FI. The Finnish company is focused on developing innovative immunotherapy approaches against cancer and infectious disease. Valo Therapeutics's lead platform, PeptiCRAd, was developed out of the laboratory of Professor Vincenzo Cerullo at the University of Helsinki. The company is also developing PeptiEnv and PeptiVax, among other neoantigen strategies, in collaboration with Professor Cerullo. The company's PeptiChip technology enables the rapid and accurate identification of tumor antigens. Valo Therapeutics is also developing antigen-coated oncolytic viruses as anti-cancer therapeutic vaccines. The company was founded in 2016, and Paul Grant Higham has been the CEO of the company since 2020.
8
| Holding Company | Pharmaceuticals: Major | 8 |
Aura Capital Oy
![]() Aura Capital Oy Investment ManagersFinance Aura Capital Oy (Aura Capital) is a private equity/venture capital subsidiary of Auratum Oy founded in 1997. The firm is headquartered in Turku, Finland.
2
| Subsidiary | Investment Managers | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Heikki Matti Kalervo Hautsalo via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
BAYER AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
NORDION INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
PNO Resources Ltd.
![]() PNO Resources Ltd. Other Metals/MineralsNon-Energy Minerals PNO Resources Ltd. engages in the acquisition and exploration of natural resource properties. The company was founded on February 22, 1983 and is headquartered in Vancouver, Canada. | Other Metals/Minerals | President | |
Bayer Pharmaceuticals Corp. | Corporate Officer/Principal | ||
Cita NeuroPharmaceuticals, Inc.
![]() Cita NeuroPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cita Neuro Pharmaceuticals, Inc. develops and commercializes small molecule drugs. Its clinical drug portfolio consists of drugs for Parkinson's disease and neuropathic pain. Cita Neuro Pharmaceuticals was founded in 1997 by Brian Bennett, Roland Boegman, Khem Jha-mandas, James Reynolds and Gregory Thatcher and is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Chief Executive Officer | |
AMCOM TELECOMMUNICATIONS LIMITED | Specialty Telecommunications | Director of Finance/CFO | |
Symbion A/S
![]() Symbion A/S General GovernmentGovernment Symbion A/S provides office communities, meeting facilities, conference facilities, business development and capital for start-up companies. The company was founded in 1986 and is headquartered in Copenhagen, Denmark. | General Government | Corporate Officer/Principal | |
Immatics Biotechnologies GmbH
![]() Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Chief Executive Officer | |
Mobidiag Oy
![]() Mobidiag Oy Miscellaneous Commercial ServicesCommercial Services Mobidiag Oy provides molecular diagnostic for infectious diseases. It develops and provides microarray-based Prove-it technology for early and diagnosis of life-threatening pathogenic microbes causing severe infections. Its Amplidiag product line comprises products for gastrointestinal pathogens and utilizes quantitative real-time polymerase chain reaction technology. The company was founded by Mart Saarma in 2000 and is headquartered in Espoo, Finland. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Medicel Oy
![]() Medicel Oy Information Technology ServicesTechnology Services Medicel Oy develops and provides software services for reverse engineering and modeling of biochemical pathways for drug discovery and validation. The company's product platforms include Medicel Integrator, Medicel Explorer, and Medicel Services. Medicel was founded in March 2001 and is headquartered in Espoo, Finland | Information Technology Services | Corporate Officer/Principal | |
Charles River Discovery Research Services Finland Oy
![]() Charles River Discovery Research Services Finland Oy Miscellaneous Commercial ServicesCommercial Services Charles River Discovery Research Services Finland Oy provides non-clinical central nervous system services to the pharmaceutical and biotechnology industries. The company was founded in 1998 and is located in Kuopio, Finland. | Miscellaneous Commercial Services | Chief Executive Officer | |
University of Copenhagen | College/University | Corporate Officer/Principal | |
International Institute for Management Development | College/University | Masters Business Admin | |
EMPIRED LIMITED | Miscellaneous Commercial Services | Director of Finance/CFO | |
ELDERS LIMITED | Agricultural Commodities/Milling | Comptroller/Controller/Auditor | |
Dansk Biotek
![]() Dansk Biotek Miscellaneous Commercial ServicesCommercial Services Dansk Biotek is an industry association for biotech companies with promoting the biotechnological research, development and production in taking care of corporate interests in this regard, both nationally and internationally. The company was founded in 1987 and is headquartered in Copenhagen, Denmark. | Miscellaneous Commercial Services | Director/Board Member | |
Inderes Oyj (Research Firm) | Investment Managers | Analyst-Equity | |
Glycotope GmbH
![]() Glycotope GmbH BiotechnologyHealth Technology Glycotope GmbH operates as a biotechnology company to develop pharmaceutical therapeutics and nutrition additives. It focuses on the optimization and humanization of therapeutically relevant sugar structures on biopharmaceuticals known as glycosylation and on the development of innovative antibodies targeting glycostructures on cell surfaces. The company was founded by Steffen Goletz and Andreas Eckert in Febraury 2001 and is headquartered in Berlin, Germany. | Biotechnology | Chief Executive Officer | |
Suomen Bioteollisuus ry | Director/Board Member | ||
Targovax Oy
![]() Targovax Oy Pharmaceuticals: MajorHealth Technology Targovax Oy focuses on the development and commercialization of targeted cancer immunotherapy. It is a biotechnology company with novel immunotherapy platform that is based on engineered oncolytic viruses armed with potent immune-stimulating transgenes. The firm's products induce a tailored response by the immune system directed at each patient’s unique cancer cells. The company was founded by Pekka Ilmari Simula and Antti Vuolanto in 2009 and is headquartered in Helsinki, Finland. | Pharmaceuticals: Major | Founder | |
Copenhagen Business Center | Corporate Officer/Principal | ||
Copenhagen University Hospital | College/University | Corporate Officer/Principal | |
Royal Perth Yacht Club | Director/Board Member | ||
OncoNOx ApS
![]() OncoNOx ApS Pharmaceuticals: MajorHealth Technology OncoNOx ApS provides drugs for the treatment of autoimmune diseases and cancer. It is a pharmaceutical company that transforms marketed drugs into proprietary molecules with anti-cancer and/or anti-inflammatory properties. The firm's projects include OX1001 and OX27-NO is a potent anti-cancer compounds in vitro and in vivo and are intended for the treatment of cancer, and OX1001 also exhibits anti-viral activity and is in development for treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome patients with or without HIV related cancer. The company was founded by Ferdinando Nicoletti, Gianni Garotta, Yousef Al-Abed, Marco Donia, and Mai-Britt Zocca in 2011 and is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Founder | |
Renovaro Biosciences Denmark ApS
![]() Renovaro Biosciences Denmark ApS Miscellaneous Commercial ServicesCommercial Services Dandrit Biotech A/S conducts clinical research, trading, and manufacturing for the pharmaceutical industry. It focuses on research and development of medicines. The company was founded on April 1, 2001 and is headquartered in Hørsholm, Denmark. | Miscellaneous Commercial Services | Chief Executive Officer | |
CIRCIO HOLDING ASA | Biotechnology | Corporate Officer/Principal | |
Governance Institute of Australia Ltd.
![]() Governance Institute of Australia Ltd. Miscellaneous Commercial ServicesCommercial Services Governance Institute of Australia Ltd. provides education, support, and networking opportunities for directors, Australian company secretaries, governance advisers, and risk managers. The private company is based in Sydney, Australia. Megan Motto has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
HERANTIS PHARMA OYJ | Pharmaceuticals: Major | Chief Executive Officer | |
Entrepreneurial Learning Lab | Corporate Officer/Principal | ||
Wirepas Oy
![]() Wirepas Oy Packaged SoftwareTechnology Services Wirepas Oy develops device connectivity applications. It applications include electricity meters, water meters, sensor, beacon and references. Wirepas was founded by Teppo Hemia and Ville Kaseva in 2010 and is headquartered in Tampere, Finland. | Packaged Software | Director/Board Member | |
IO Biotech ApS
![]() IO Biotech ApS BiotechnologyHealth Technology IO Biotech ApS operates as a clinical stage biotech company. It develops immunotherapy for cancer by targeting a mechanism used by tumour cells to evade immune responses. The company was founded by Mai-Britt Zocca, Mads Hald Andersen, Inge Marie Svane, Anders Ljungqvist and Per Thor Straten and is headquartered in Copenhagen, Denmark. | Biotechnology | Chief Executive Officer | |
Innovestor Ventures Oy
![]() Innovestor Ventures Oy Investment ManagersFinance Innovestor Ventures Oy is a venture capital firm, a subsidiary of Innovestor Oy founded in 2014. The firm is headquartered in Helsinki, Finland. | Investment Managers | Private Equity Investor | |
NFT Ventures Finland Oy | Investment Managers | Private Equity Investor | |
EduImpact Venture Capital Oy
![]() EduImpact Venture Capital Oy Investment ManagersFinance EduImpact Venture Capital Oy (EduImpact) is a venture capital firm founded in 2017 by Marko Kyyrönen, Antti Korhonen and Janne Rainvuori. The firm is headquartered in Helsinki, Finland. | Investment Managers | Private Equity Investor | |
HERAMED LIMITED | Packaged Software | Director/Board Member | |
The Australia Day Council WA, Inc. | Director/Board Member | ||
Valo Therapeutics Ltd. | Chief Executive Officer | ||
Helsinki Innovation Services Ltd.
![]() Helsinki Innovation Services Ltd. Miscellaneous Commercial ServicesCommercial Services Part of University of Helsinki, Helsinki Innovation Services Ltd. is a company that provides business and innovation-related consulting services. The company is based in Helsinki, Finland. | Miscellaneous Commercial Services | Chief Operating Officer | |
Aalto University School of Science & Technology | College/University | Graduate Degree Doctorate Degree | |
Tribune Therapeutics AB
![]() Tribune Therapeutics AB Miscellaneous Commercial ServicesCommercial Services Tribune Therapeutics AB is a preclinical biopharmaceutical company that focuses on developing novel medicines to treat patients with fibrotic diseases. Healthcap and Novo Seeds provided funding for the company, and they are based in Stockholm, Sweden. The Swedish company was created by Healthcap and Novo Seeds, the early-stage investment and company creation team of Novo Holdings. The company was founded in 2020 and has in-licensed an asset from one of the largest technology transfer offices in the Nordic region. The founders of the company are Håvard Attramadal, Ole J. Kaasbøll, and Georg Vo Beiske, who has been the CEO since 2020. | Miscellaneous Commercial Services | Director/Board Member | |
Cobis A/S
![]() Cobis A/S Miscellaneous Commercial ServicesCommercial Services Cobis A/S provides business support services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Teitur Trophics ApS
![]() Teitur Trophics ApS BiotechnologyHealth Technology Teitur Trophics ApS develops novel treatments. The company is based in Aarhus, Denmark. The Danish company was founded by Simon Mølgaard, Mathias Kaas Ollendorff, Anders Dalby, Simon Glerup. Simon Mølgaard has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
Neumirna Therapeutics ApS | Biotechnology | Director/Board Member | |
Bocap Investment Oy
![]() Bocap Investment Oy Investment ManagersFinance Bocap Investment Oy (Bocap) is an independent private equity firm founded in 2012 by Julianna Borsos. The firm is headquartered in Helsinki, Finland. | Investment Managers | Private Equity Investor |
Statistics
International
Finland | 17 |
Denmark | 14 |
Australia | 8 |
Canada | 5 |
United Kingdom | 4 |
Sectoral
Health Technology | 16 |
Commercial Services | 12 |
Finance | 6 |
Consumer Services | 5 |
Technology Services | 4 |
Operational
Director/Board Member | 27 |
Corporate Officer/Principal | 17 |
Chief Executive Officer | 15 |
Private Equity Investor | 10 |
President | 9 |
Most connected contacts
- Stock Market
- Insiders
- Heikki Matti Kalervo Hautsalo
- Company connections